ESC Premium Access

Cryoballoon ablation of atrial fibrillation in low and medium volume hospitals - experiences of the German REGIONAL registry

Congress Session

About the speaker

Doctor Jochen Michaelsen

St. Bonifatius Hospital, Lingen (Germany)
0 follower

23 more presentations in this session

Left atrial dysfunction still exists in patients who obtain normal left atrial volume after successful ablation of atrial fibrillation.

Speaker: Doctor H. Kawakami (Toon, JP)

Thumbnail

Same day discharge after atrial fibrillation ablation is feasible and safe. Results of a prospective study in 1015 patients

Speaker: Mr M. Viezelis (Kaunas, LT)

Thumbnail

Benefits of early intervention with catheter ablation in patients with atrial fibrillation

Speaker: Doctor S. Mohanty (Austin, US)

Thumbnail

Accuracy comparison of the new and previous Kodex occlusion tool software versions to assess pulmonary vein occlusion in atrial fibrillation cryoablation

Speaker: Doctor M. Polselli (Rome, IT)

Thumbnail

Bystander dispatcher-assisted cardiopulmonary resuscitation for the likelihood of an initial shockable rhythm after out-of-hospital cardiac arrest

Speaker: Professor Y. Goto (Kanazawa, JP)

Thumbnail

Access the full session

Congress committee e-posters choice in arrhythmias and device therapy

Speakers: Doctor J. Michaelsen, Doctor H. Kawakami, Mr M. Viezelis, Doctor S. Mohanty, Doctor M. Polselli...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

EHRA Premium Access

Comparison of safety and efficacy between POLARx and Arctic Front cryoballoon ablation

4 April 2022

EHRA Premium Access

Biophysical parameters and time to isolation of pulmonary veins with a novel cryoballoon: results of POLAR ICE study

3 April 2022

EHRA Premium Access

Selective epicardial pulsed field ablation of atrial ganglionated plexi causes anti-arrhythmic prolongation of refractoriness: demonstration of feasibility in cardiac surgery patients

3 April 2022

This platform is supported by

logo Novo Nordisk